Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-11-21

FDA Approved: ABACAVIR — Original Application (Cipla USA Inc.)

View source ↗

Summary

The FDA approved Cipla USA's generic abacavir under an original ANDA for use in HIV-1 infection as part of combination antiretroviral therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • abacavir (abacavir)

Snippet

ORIG AP for ABACAVIR (ABACAVIR)